What is Osler Rendu syndrome?
Osler-Weber-Rendu disease (OWRD) is a rare autosomal dominant disorder that affects blood vessels throughout the body (causing vascular dysplasia) and results in a tendency for bleeding. (The condition is also known as hereditary hemorrhagic telangiectasia [HHT]; the two terms are used interchangeably in this article.)
Is Osler-Weber-Rendu syndrome rare?
Osler-Weber-Rendu disease, also known as hereditary hemorrhagic telangiectasia, is a rare autosomal dominant condition causing systemic fibrovascular dysplasia. It has an incidence of 1-2/100,000.
What causes Osler-Weber-Rendu syndrome?
What Causes Osler-Weber-Rendu Syndrome? People with OWR inherit an abnormal gene that causes their blood vessels to form incorrectly. OWR is an autosomal dominant disorder. This means that only one parent needs to have the abnormal gene to pass it on to their children.
How do you test for Osler-Weber-Rendu syndrome?
Imaging tests, such as magnetic resonance imaging (MRI) and computed tomography (CT), are used to look at the cerebrovascular system (the blood vessels in the brain) and gastrointestinal system (the stomach and intestines). An MRI or CT scan also may be used to look for areas of that may have been damaged by a stroke.
Is hereditary hemorrhagic telangiectasia painful?
HHT-related GI bleeding risk increases with age. Telangiectasia in the GI tract do not cause pain. Symptoms of GI bleeding include black or bloody stool and/or anemia.
How common is HHT disease?
What Is Hereditary Hemorrhagic Telangiectasia (Also Known as Osler Weber Rendu Syndrome)? Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder that affects about 1 in 5,000 to 1 in 10,000 people and commonly causes nosebleeds, with more frequent nosebleeds typically starting after about age 12.
What is the treatment for HHT?
One of the most promising treatments for HHT is bevacizumab (Avastin) given through a tube in a vein (intravenously). Other drugs that block blood vessel growth are being studied for HHT treatment. Examples include pazopanib (Votrient) and pomalidomide (Pomalyst). Drugs that slow the disintegration of clots.
What is hereditary hemorrhagic telangiectasia HHT?
HHT is a disorder in which some blood vessels do not develop properly. A person with HHT may form blood vessels without the capillaries (tiny blood vessels that pass blood from arteries to veins) that are usually present between arteries and veins.
Can telangiectasia go away?
There is no cure for telangiectasia, but the condition is treatable. Doctors will often devise a treatment plan based on the results of diagnostic tests. For example, if acne or rosacea is the underlying cause, the doctor may prescribe an oral or topical antibiotic.
